Paraplatin and Adverse event - a phase IV clinical study of FDA data

Summary:

Adverse event is reported as a side effect among people who take Paraplatin (carboplatin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Taxol, and have Oestrogen receptor assay positive.

The phase IV clinical study analyzes which people have Adverse event when taking Paraplatin. It is created by eHealthMe based on reports of 12,385 people who have side effects when taking Paraplatin from the FDA, and is updated regularly.

What is Paraplatin?

Paraplatin has active ingredients of carboplatin. eHealthMe is studying from 12,392 Paraplatin users. Check the latest studies of Paraplatin.

What is Adverse event?

Adverse event is found to be associated with 1,672 drugs and 1,674 conditions by eHealthMe. Check the latest studies of Adverse event.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

12,385 people reported to have side effects when taking Paraplatin.
Among them, 13 people (0.1%) have Adverse event.

Among these 13 people:

How long have people been on Paraplatin when they have Adverse event? *

What is the gender of people who have Adverse event when taking Paraplatin? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Adverse event when taking Paraplatin? *

What are other drugs people take besides Paraplatin? *

What are other side effects people have besides Adverse event? *

Hospitalisation: 2 people, 15.38%
Weight Decreased: 1 person, 7.69%
Flatulence (flatus expelled through the anus): 1 person, 7.69%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 7.69%
Fatigue (feeling of tiredness): 1 person, 7.69%
Ejection Fraction Decreased (systolic heart failure): 1 person, 7.69%
Dry Skin: 1 person, 7.69%
Drowsiness: 1 person, 7.69%
Dehydration (dryness resulting from the removal of water): 1 person, 7.69%
Death: 1 person, 7.69%

What are the existing conditions these people have? *

Oestrogen Receptor Assay Positive: 2 people, 15.38%
Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 1 person, 7.69%
Progesterone Receptor Assay Positive: 1 person, 7.69%
Ovarian Cancer (cancer of ovary): 1 person, 7.69%
Neoplasm Malignant (cancer tumour): 1 person, 7.69%
Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 1 person, 7.69%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 7.69%
Breast Cancer: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Paraplatin and have Adverse event?

- Check whether Adverse event is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Paraplatin:

Paraplatin (12,392 reports)

Adverse event treatments and more:

Adverse event (100,133 reports)

Browse all side effects of Paraplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Adverse event:

Adverse event (1,672 drugs)

Browse all the conditions that are associated with Adverse event:

Adverse event (1,674 conditions)

Related publications that referenced our studies

Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .
Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on carboplatin (the active ingredients of Paraplatin) and Paraplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.